ArticlePloS one2026
Lifetime HIV testing frequency among women in Sub-Saharan Africa: A DHS-based analysis using zero-inflated negative binomial regression.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHIV testing is an essential component of HIV prevention and care, yet lifetime testing frequency remains low in sub-Saharan Africa (SSA). This study examines the factors influencing lifetime HIV testing frequency among reproductive-age women in SSA.
methodsWe analyzed the most recent Demographic and Health Survey (DHS) data from nine sub-Saharan African countries, with an overall weighted sample of 158,722 women aged 15-49. The dependent variable was the lifetime number of HIV tests, and Zero-Inflated Negative Binomial (ZINB) regression was used. Model selection was based on Akaike Information Criterion (AIC) or Bayesian Information Criterion (BIC) and Vuong's test, favoring the ZINB model over other count models. Adjusted incidence rate ratios (aIRRs) for the count and aOR for the inflation part with 95% confidence intervals (CIs) were reported, with statistical significance set at p < 0.05.
resultsThe mean number of lifetime HIV tests was 2.49 (SD = 7.67), with a median of 0 (IQR = 0-3). Key predictors of lifetime HIV testing included: age (30-39 years: aIRR = 2.94; 40-49 years: aIRR = 3.14), rural residence (aIRR = 1.10), current or former union (aIRR = 1.37 and 1.30, respectively), education (primary: aIRR = 1.19; secondary: aIRR = 1.35; higher: aIRR = 1.81), wealth (richer: aIRR = 1.30; richest: aIRR = 1.34), and employment (manual labor: aIRR = 1.21; skilled work: aIRR = 1.18). Other significant factors included: comprehensive HIV knowledge (aIRR = 1.37), STI awareness (aIRR = 2.21), media exposure (aIRR = 1.25), access to health facilities (aIRR = 1.26), number of sexual partners (1 partner: aIRR = 4.82; 2-3 partners: aIRR = 5.67; 4 or more partners: aIRR = 6.13), early sexual debut (aIRR = 0.61), and region (East Africa: aIRR = 2.82; Southern Africa: aIRR = 7.25). The inflation model showed very low odds of never testing among women with primary and secondary education, lower odds with media exposure (OR=0.40), but higher odds with higher education (OR=5.26) and rural residence (OR=1.93).
conclusionsThis study indicated that over half of women of reproductive age in SSA have never tested for HIV. Addressing socio-economic, structural, and regional disparities, particularly in West Africa, is crucial, highlighting the need for targeted, equitable, and community-based strategies to expand testing coverage and promote repeat uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.